If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeltic Regulatory News (CCP)

Share Price Information for Celtic (CCP)

Share Price is delayed by 15 minutes
Get Live Data
229.00    -1.00 (-0.43%)
Bid:
224.00
Ask:
234.00
Spread: 10.00 (4.464%)
Market Cap: £217.76m
CCP Live PriceLast checked at - London Stock Exchange

Intraday Celtic Share Chart

Issued share capital

4 Mar 2008 07:01

Celtic PLC04 March 2008 CELTIC PLC Issued share capital4 March 2008 As a result of conversion of 21,600 Convertible Preferred Ordinary Shares of100p ("CPO Shares") in the capital of Celtic plc during February 2008, theCompany's issued share capital at 29 February 2008 was as follows: 88,598,741 Ordinary Shares of 1p each14,509,591 Cumulative Convertible Preferred Ordinary Shares of 100p each16,795,912 Cumulative Convertible Preference Shares of 60 p each443,540,951 Deferred Shares of 1p each Cumulative Convertible Preference Shares do not carry voting rights. DeferredShares are not listed, are not transferable and carry no voting rights orsubstantive economic rights. The above figures for Ordinary Shares and CPO Shares may be used by shareholdersas the denominator for the calculations by which they will determine if they arerequired to notify their interest in, or a change in their interest, under theFSA's Disclosure and Transparency Rules. Application has been made for the 43,680 new Ordinary Shares of 1p each arisingfrom the conversion of CPO shares to be listed with effect from 12 March 2008. End. Enquiries: Jonathan Wright +44 (0) 207 107 8000Seymour Pierce Limited This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Jul 20235:45 pmRNSIssue of Equity
19th Jul 20237:30 amRNSNon-Executive Director Appointment
11th Jul 20234:30 pmRNSIssue of Equity
6th Jul 20234:00 pmRNSTrading update for the year ended 30 June 2023
4th Jul 20235:00 pmRNSIssue of Equity
19th Jun 202312:00 pmRNSAppointment of Brendan Rodgers
6th Jun 202310:25 amRNSAnge Postecoglou to leave Celtic
31st May 202311:00 amRNSIssue of Equity
16th May 20237:00 amRNSIssue of Equity
20th Apr 20232:30 pmRNSIssue of Equity
5th Apr 202312:00 pmRNSIssue of Equity
2nd Mar 20238:45 amRNSIssue of Equity
21st Feb 20237:00 amRNSIssue of Equity
10th Feb 20235:10 pmRNSHalf-year Report
11th Jan 20237:00 amRNSIssue of Equity
2nd Dec 202212:30 pmRNSAppointment of Non-Executive Chairman
30th Nov 20227:00 amRNSIssue of Equity
4th Nov 20225:10 pmRNSResult of AGM
12th Oct 20227:00 amRNSNotice of AGM
20th Sep 20225:30 pmRNSResults for the year ended 30 June 2022
31st Aug 20227:00 amRNSIssue of Equity
5th Aug 202210:19 amRNSScrip Dividend Price
29th Jul 20224:00 pmRNSRetirement of Ian Bankier
21st Jul 20227:00 amRNSDividend Timetable
22nd Jun 20221:30 pmRNSFull year results for the year ended 30 June 2022
22nd Jun 20227:00 amRNSIssue of Equity
17th Jun 20223:10 pmRNSHolding(s) in Company
13th May 202212:00 pmRNSIssue of Equity
11th Feb 20226:30 pmRNSReplacement: Half-year Report
11th Feb 20225:46 pmRNSHalf-year Report
23rd Dec 20211:00 pmRNSCONFIRMATION OF CHIEF EXECUTIVE
17th Nov 20216:20 pmRNSResult of AGM
22nd Oct 20214:00 pmRNSNotice of AGM
21st Sep 20217:00 amRNSResults for the year ended 30 June 2021
10th Sep 20214:30 pmRNSDirectorate change
31st Aug 202110:00 amRNSIssue of Equity
5th Aug 20213:00 pmRNSScrip Dividend Price
22nd Jul 20214:30 pmRNSDividend Timetable
22nd Jun 20217:00 amRNSHolding(s) in Company
10th Jun 20218:51 amRNSAppointment of Ange Postecoglou
19th May 20214:30 pmRNSIssue of Equity
12th May 20211:00 pmRNSIssue of Equity
5th May 202111:00 amRNSIssue of Equity
19th Apr 20216:10 pmRNSIssue of Equity
6th Apr 202111:00 amRNSCeltic Club Statement
24th Feb 20217:00 amRNSNeil Lennon to depart Celtic
15th Feb 20217:00 amRNSHalf-year Report
29th Jan 20217:00 amRNSDirectorate Change
14th Dec 20201:06 pmRNSResult of AGM
16th Nov 20206:00 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.